Nevertheless, BCSCs, as a main source of cancer relapse, remained largely intact in vitro upon CDK4/6i, HR antagonists, and autophagy inhibition in ER+ breast cancer cells [164]. This evidence concerns the gene CDK4 and breast cancer.